title: Repeat exposure to active tuberculosis and risk of re-infection.
authors.affiliation: Liverpool Hospital, Sydney, NSW c.dobler@unsw.edu.au.
authors.forename: Claudia C
authors.initials: CC
authors.lastname: Dobler
authors.affiliation: Liverpool Hospital, Sydney, NSW.
authors.forename: Roujan
authors.initials: R
authors.lastname: Chidiac
authors.affiliation: Liverpool Hospital, Sydney, NSW.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Williamson
authors.affiliation: Westmead Hospital, Sydney, NSW.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Jelfs
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control; D004636:Emergency Service, Hospital; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D010290:Parents; D011718:Pyrazinamide / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors; D035781:Siblings; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology / Q000635:transmission*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin